Leaderboard

En | De
Sie sind hier: Hämatologie » Neoplasie 17. September 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Anämie
Gerinnungsstörungen
Neoplasie
Anderes
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8516  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 170302  
   
Molecular study of KIT gene that is related to drug resistance in chronic myeloid leukemia patients.
J Genet Eng Biotechnol
Salman AK, Dhamad AE.
PMID: 42749439 [PubMed]


Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.
N Engl J Med
Schrappe M, Locatelli F, Valsecchi MG, Zugmaier G, Vossen-Gajcy M, Starý J, Attarbaschi A, Möricke A, Bourquin JP, Barbaric D, Elitzur S, Silvestri D, Kolenova A, Dalla-Pozza L, Bodmer N, Stanulla M, Alten J, Zaman F, Bergmann A, Cazzaniga G, Brüggemann M, Buldini B, Köhler R, Fazio G, Rössig C, Sramkova L, Parasole R, Hundsdörfer P, Putti MC, Borkhardt A, Fagioli F, Bettini LR, Poyer F, von Stackelberg A, Vinti L, Conter V, Zimmermann M, Rizzari C, Cario G, Biondi A, AIEOP-BFM ALL 2017 Consortium.
PMID: 42748428 [PubMed - indexed for MEDLINE]


Letter to the editor regarding 'Real-world venetoclax dosing patterns and treatment persistence in patients with acute myeloid leukemia: a community pharmacy database study in Japan'.
Leuk Lymphoma
Borrás-Blasco J, Valcuende-Rosique A, Cornejo-Uixeda S.
PMID: 42747324 [PubMed - as supplied by publisher]


Real-World Determinants of Treatment Selection in Frontline Chronic Lymphocytic Leukemia: The FIRST-CLL Study.
Hematol Oncol
Perutelli F, Arata M, Pasquale R, Pepe S, Nicolosi M, Deodato M, Piras I, Fioribello E, Bosi A, Moia R, Ferrario A, Schirru M, Boccellato E, Bullo M, Gottardi D, Foglietta M, Galitzia A, Coscia M, Gaidano G, Merli M, Salvetti C, Murru R, Frustaci AM, Freilone R, Olivieri J, Mauro FR, Bruno B, Vitale C.
PMID: 42747083 [PubMed - indexed for MEDLINE]


Efficacy and safety of chimeric antigen receptor T-cell therapy in primary central nervous system lymphoma: a systematic review and meta-analysis.
Immunotherapy
Al-Mashdali AF, Abdelraof MO, Kaddoura R, Halfawi AM, Yousif MEM, Abdulgayoom M, Shah AR, Mohamed SF.
PMID: 42746886 [PubMed - as supplied by publisher]


Targeting lipid metabolic vulnerabilities with small-molecule inhibitors in acute myeloid leukemia: Emerging insights and therapeutic opportunities.
Tzu Chi Med J
Yen JH, Phan TQ, Liou JW, Chen PY.
PMID: 42746650 [PubMed]


Case Report: Blastic plasmacytoid dendritic cell neoplasm mimicking systemic lymphoma: a multidisciplinary diagnostic challenge.
Front Med (Lausanne)
Lv B, Rong Q, Li Y, Zhang D.
PMID: 42745818 [PubMed]


Predictors and outcomes of recurrent bloodstream infection in hematological malignancies: a multicenter real-world study.
Front Cell Infect Microbiol
Tang Y, Yan Y, Zhao K, Cheng Q, Wang L, Xiao Y, Fang Z, Wei Y, Li X.
PMID: 42745743 [PubMed - indexed for MEDLINE]


Plain language summary of the ZUMA-5 study of axicabtagene ciloleucel for people with relapsed or refractory slow-growing non-Hodgkin lymphoma.
Future Oncol
Neelapu SS, Nikolajeva O, Jacobson CA.
PMID: 42745632 [PubMed - as supplied by publisher]


Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024.
Cancer Med
Zheng D, Nold T, Ramakrishnan N, Kim K, Tomassetti S.
PMID: 42745440 [PubMed - indexed for MEDLINE]


Experiences and coping strategies of time toxicity in young and middle-aged patients with lymphoma: a descriptive qualitative study.
Support Care Cancer
Li D, Zheng K, Chen L, Zhang M.
PMID: 42744956 [PubMed - indexed for MEDLINE]


Measurable residual disease detected by next-generation sequencing in T-cell acute lymphoblastic leukemia.
Nat Commun
Liao C, Chen H, Xu L, Lin S, Zhang J, Xu W, Liang J, Zhao F, Shen D, Shen H, Song H, Tang Y, Xu X.
PMID: 42744807 [PubMed - indexed for MEDLINE]


Primary central nervous system lymphoma involving the hypothalamic-pituitary axis presenting with hypopituitarism: A case report with long-term follow-up.
Endocrinol Diabetes Nutr (Engl Ed)
Sanchis-Pascual D, Cámara Gómez R, Morillas-Amat P, Romero Domínguez S, Carreres-Polo J, Lara-Gálvez D, Cano-Jiménez L, Díaz Nohales J, Merino-Torres JF.
PMID: 42744529 [PubMed - indexed for MEDLINE]


Occupational exposure to radiofrequency electromagnetic fields and risk of follicular lymphoma: Family case-control study.
Cancer Epidemiol
Mate R, Benke G, Loughran SP, Abramson MJ, Vajdic CM, Turner MC, Turuban M, Cardis E, Van Leeuwen MT, Odutola M, Hertzberg M, Bruinsma F, Seymour JF, Prince HM, Roncolato F, Opat S, Milliken S, Verner E, Lindeman R, Karipidis K.
PMID: 42743897 [PubMed - as supplied by publisher]


Treatment of acute myeloid leukemia with inv(3) or t(3;3): A single-center retrospective cohort study and literature review.
Leuk Res
Resto-Santos DM, Perissinotti AJ, Bixby DL, Burke PW, Pettit KM, Marini BL.
PMID: 42743820 [PubMed - as supplied by publisher]


High-risk features in adult patients with B-cell acute lymphoblastic leukemia: redefining risk in the era of targeted immunotherapy.
Blood Res
Baek DW.
PMID: 42742788 [PubMed]


Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta-analysis and systematic review of 1,388 patients.
Oncol Lett
Sun L, Li W, Chen W, Li C, Ren Z, Xie Q, Wang D.
PMID: 42741313 [PubMed]


Clinical implementation of intensity modulated proton therapy in breath-hold for mediastinal lymphoma patients using surface monitoring and nasal high-flow therapy.
Phys Imaging Radiat Oncol
Vilches-Freixas G, van der Klugt K, Canters R, Kneepkens E, Vereijken F, Cobben M, van den Bosch M, Lubken I, van Engelen A, Stultiens C, Velders M, Cartechini G, Unipan M, Berbée M, Ta B.
PMID: 42740833 [PubMed]


Timing matters: Impact of covalent BTK inhibitor dose modifications on outcomes in chronic lymphocytic leukemia/small lymphocytic leukemia-A 7-year real-world study.
Cancer
Zhang J, Luo J, Shen X, Ren J, Liu W, Chen L, Jiang L, Weng X, Wang J, Mi JQ.
PMID: 42740716 [PubMed - indexed for MEDLINE]


Correction: Venetoclax plus Modified-Intensity Idarubicin and Cytarabine Treatment as First-Line Treatment for Newly Diagnosed Pediatric Acute Myeloid Leukemia.
Clin Cancer Res
Wang S, Jiang M, Wang Y, Chang L, Zhao B, Liu X, Qi B, Wang S, Liu T, Zhang X, Chen Y, Liu F, Guo Y, Chen X, Zhang L, Zou Y, Yang W, Gao J, Zhu X, Ruan M.
PMID: 42740585 [PubMed - in process]


   
   Artikel 1 - 20 / 170302    Seite 1 von 8516  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1